Managing Massive Hemoptysis

Davidson, K. Erin; Shojaee, Samira

doi:10.1016/j.chest.2019.07.012

Cited by 142 publications

(138 citation statements)

References 72 publications

Supporting

Mentioning

109

Contrasting

Unclassified

Order By: Relevance

“…Biopsy-site-down lateral positioning is effective for doing so. The patient's ability to expectorate aspirated blood is also salient for maintaining the airway (83). Massive, potentially fatal, hemoptysis may develop after PTNB.…”

Section: Summary Of Guidelines and Commentsmentioning

confidence: 99%

“…Massive hemoptysis is traditionally defined as an amount of hemoptysis of 600 mL or larger within 24 hours (84). However, measuring the amount of hemoptysis is challenging in practice, and thoracic interventionists need to determine the severity of hemoptysis by systematically considering not only the volume of hemoptysis, but also the rate of bleeding, the degree of hemodynamic instability, oxygen desaturation (36), and the patient's physiological reserves (83). It is essential to monitor vital signs and resuscitate the patient from oxygen desaturation via an oxygen supply in the biopsy-site-down position (2).…”

Section: Summary Of Guidelines and Commentsmentioning

confidence: 99%

See 1 more Smart Citation

2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology

et al. 2021

View full text Add to dashboard Cite

Percutaneous transthoracic needle biopsy (PTNB) is one of the essential diagnostic procedures for pulmonary lesions. Its role is increasing in the era of CT screening for lung cancer and precision medicine. The Korean Society of Thoracic Radiology developed the first evidence-based clinical guideline for PTNB in Korea by adapting pre-existing guidelines. The guideline provides 39 recommendations for the following four main domains of 12 key questions: the indications for PTNB, pre-procedural evaluation, procedural technique of PTNB and its accuracy, and management of post-biopsy complications. We hope that these recommendations can improve the diagnostic accuracy and safety of PTNB in clinical practice and promote standardization of the procedure nationwide.

show abstract

Section: Summary Of Guidelines and Commentsmentioning

confidence: 99%

Section: Summary Of Guidelines and Commentsmentioning

confidence: 99%

2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology

et al. 2021

View full text Add to dashboard Cite

show abstract

“…It has multiple causes, but spinal rod penetration into the lung, is extremely rare. Usually, an assessment of the clinical significance of hemoptysis should consider the volume of expectorated blood and its effects on the respiratory and cardiovascular reserves of the patient [ 1 ]. Our patient presented with slight hemoptysis and had no other complaints.…”

Section: Discussionmentioning

confidence: 99%

“…The diagnostic procedures should identify both, the source, and the underlying cause. Common causes include bronchiectasis, tuberculosis, and malignancy; however many other conditions such as cardiac, rheumatologic or vascular diseases can also cause hemoptysis [ 1 ]. We present an unusual case of hemoptysis as a delayed complication of scoliosis surgery.…”

Section: Introductionmentioning

confidence: 99%

Unusual cause of hemoptysis: A case report

Fijołek¹,

Oniszh²

2020

Annals of Medicine and Surgery

View full text Add to dashboard Cite

Hemoptysis is defined as bleeding from the lower respiratory tract. It can be life-threatening and requires urgent investigation and intervention. Common causes of hemoptysis include bronchiectasis, tuberculosis, aspergilomas and malignancy. We present an unusual case of hemoptysis in a young woman with a history of surgery for scoliosis 18 years earlier. A 30-years-old woman was admitted to our institution for recurring hemoptysis since one year. She had a history of scoliosis and had undergone antero-lateral Th7 through Th12 spinal fusion surgery 18 years earlier. The hemoptysis was slight and resolved spontaneously or after empirical antibiotic therapy, and was attributed to bronchitis. Computed tomography revealed spinal rod penetration into the lung resulting in injury, while the caudal edge of the rod migrated into the liver and the joining screws had entered the mediastinum. Hemoptysis was due to penetration of the rod into the lung. The patient underwent extensive surgery, which was successful. The case highlights the need for thorough evaluation of patients with hemoptysis. Every incident of hemoptysis, even if minor, should be promptly investigated, because it can be life-threatening.

show abstract

“…There were 17 cases whose identi ed species of NTM were other than MAC, and 4 cases were cured by surgery; the number of patients with de nite MAC lung disease was 186. Since pulmonary tuberculosis and aspergillosis are major infectious diseases that, as well as NTM, can cause hemoptysis [16], 14 patients with treated or active pulmonary tuberculosis and 13 patients with coexisting pulmonary aspergillosis were also excluded. Hence, a total of 155 cases of MAC lung disease were enrolled in the present study ( Fig.…”

Section: Study Populationmentioning

confidence: 99%

Association of Serum Antibodies Against the Mycobacterium Avium Complex and Hemoptysis: A Cross-Sectional Study

Ogata

Moriwaki

Nakagawa

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Hemoptysis is very common and can be life threatening in clinical practice for nontuberculous mycobacteria. The serum antibody against the Mycobacterium avium complex (MAC-Ab), the majority of nontuberculous mycobacteria species, is well known to reflect the activity of MAC lung disease; however, there is no study investigating the association between the MAC-Ab and hemoptysis in MAC patients. Therefore, we assessed whether the MAC-Ab is a good biomarker for hemoptysis among subjects with MAC lung disease. Methods: This study was conducted as a five-year retrospective survey at the National Hospital Organization Fukuoka National Hospital. A total of 155 patients aged ≥ 20 years with MAC lung disease were enrolled and separated into seropositive and seronegative groups using the cutoff for MAC-Ab levels of 0.7 U/ml. The prevalence of hemoptysis and odds ratios for the presence of hemoptysis were estimated and compared between the groups. To investigate the linear trends in the relationship between MAC-Ab levels and hemoptysis, the subjects were classified into three groups using the tertile distribution of the MAC-Ab. Results: The prevalence of hemoptysis was twice as high in the seropositive group than in the seronegative group (42.2% and 21.7%, respectively, P = 0.02). The multivariable-adjusted risk of hemoptysis was elevated in the seropositive group as compared with the seronegative group (odds ratio = 2.79 (95% confidence interval 1.15–7.44)). Likewise, when categorizing the subjects into three groups, the risk of hemoptysis increased parallel to higher MAC-Ab levels (P = 0.03 for trend). Conclusions: A positive MAC-Ab level was a significant risk factor for hemoptysis among patients with MAC lung disease. There were also positive trends in the association between the MAC-Ab titer and the likelihood of hemoptysis. MAC patients who tested positive for the MAC-Ab should be carefully followed up for the potential development of hemoptysis.

show abstract

Managing Massive Hemoptysis

Cited by 142 publications

References 72 publications

2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology

2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology

Unusual cause of hemoptysis: A case report

Association of Serum Antibodies Against the Mycobacterium Avium Complex and Hemoptysis: A Cross-Sectional Study

Contact Info

Product

Resources

About